A 52-year-old man from rural India presents with chronic epigastric pain, early satiety, and weight loss over 6 months. Upper endoscopy shows chronic gastritis with intestinal metaplasia. Serum antibodies to Helicobacter pylori are positive. All of the following statements regarding H. pylori pathogenesis and management are true EXCEPT:

Explanation

## Helicobacter pylori: Pathogenesis and Eradication Therapy ### Correct Answer: Triple Therapy Eradication Rate **Key Point:** Standard triple therapy (PPI + amoxicillin + metronidazole) does NOT achieve >95% eradication rates in India. Due to rising metronidazole resistance (30–50% in India) and increasing fluoroquinolone resistance, eradication rates with standard triple therapy have declined to 60–80% in many regions, including India. Current guidelines recommend quadruple therapy (PPI + bismuth + metronidazole + tetracycline) or sequential therapy as first-line. **Warning:** Citing >95% eradication for standard triple therapy is outdated and does not reflect current Indian epidemiology. This is a common trap in NEET PG questions. ### Why the Other Options Are Correct | Statement | Evidence | |-----------|----------| | **Urease production** | H. pylori produces urease → ammonia generation → local pH neutralization → survival in acidic gastric juice [cite:Harrison 21e Ch 155] | | **CagA pathogenicity** | CagA+ strains inject CagA protein into epithelial cells → chronic inflammation → increased gastric cancer (3–6 fold) and MALT lymphoma risk | | **Microaerophilic spiral rod** | Gram-negative, spiral/curved morphology; microaerophilic (requires 5% O₂); colonizes gastric mucosa beneath mucus layer | ### Current H. pylori Eradication Regimens in India ```mermaid flowchart TD A[H. pylori Eradication Therapy]:::outcome --> B{First-line choice}:::decision B -->|Low resistance area| C[Quadruple therapy<br/>PPI + Bismuth + Metronidazole + Tetracycline<br/>14 days]:::action B -->|High resistance area| D[Sequential therapy<br/>PPI + Amoxicillin 5 days<br/>then PPI + Clarithromycin + Metronidazole 5 days]:::action C --> E[Eradication rate: 85-95%]:::outcome D --> F[Eradication rate: 90-95%]:::outcome G[Avoid standard triple therapy<br/>due to resistance]:::urgent ``` ### High-Yield: Resistance Patterns in India - **Metronidazole resistance:** 30–50% (most common) - **Clarithromycin resistance:** 10–20% (increasing) - **Fluoroquinolone resistance:** 15–25% (rising) - **Amoxicillin resistance:** <5% (still reliable) **Clinical Pearl:** In India, quadruple therapy (PPI + bismuth + metronidazole + tetracycline for 14 days) or sequential therapy is now preferred over standard triple therapy to overcome resistance and achieve >85% eradication. ### Complications of Untreated H. pylori 1. Chronic gastritis → intestinal metaplasia → gastric adenocarcinoma (intestinal type) 2. MALT lymphoma (mucosa-associated lymphoid tissue) 3. Peptic ulcer disease 4. Functional dyspepsia **Mnemonic:** **CAMP** — CagA, Adhesins, Motility, Persistent infection = virulence factors of H. pylori.